Pfizer: Diabetes Mellitus, Type 2 trials
The registry lists 80 Diabetes Mellitus, Type 2 studies with Pfizer as lead sponsor. 2 are open to participants now and 39 have results posted.
Phase 1 47Phase 2 18Phase 3 9Phase 4 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)RecruitingNCT07915609Phase 3
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 3
- A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney DysfunctionTerminatedNCT05510245Phase 1Results posted
- Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusCompletedNCT05158244Phase 1Results posted
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes MellitusCompletedNCT04889157Phase 1Results posted
- STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENTCompletedNCT04616027Phase 1Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes MellitusCompletedNCT04552470Phase 1Results posted
- Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusCompletedNCT04305587Phase 1Results posted
- A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes MellitusCompletedNCT03985293Phase 2Results posted
- A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusCompletedNCT03969719Phase 2Results posted
- 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 DiabetesCompletedNCT03538743Phase 1Results posted
- A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On MetforminCompletedNCT02554877Phase 2Results posted
- A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As MonotherapyCompletedNCT02292433Phase 1Results posted
- A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes MellitusCompletedNCT02211261Phase 1Results posted
- Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.CompletedNCT02206607Phase 1Results posted
- Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes MellitusCompletedNCT02175121Phase 2Results posted
- Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 DiabetesCompletedNCT01933672Phase 1Results posted
- Multiple Dose Study Of PF-05231023 In Obese Adult SubjectsTerminatedNCT01923389Phase 1Results posted
- PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus PatientsCompletedNCT01856595Phase 1Results posted
- Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary ParametersCompletedNCT01819922Phase 1Results posted
- A 6-Week Study Of PF-05175157 In Type 2 Diabetes MellitusTerminatedNCT01792635Phase 2Results posted
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt NephropathyCompletedNCT01712061Phase 2Results posted
- Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes MellitusCompletedNCT01673178Phase 1Results posted
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On MetforminCompletedNCT01517373Phase 2Results posted
- Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 DiabetesCompletedNCT01475461Phase 2Results posted
- A 2-week Trial Of PF-04991532 In Patients With Type 2 DiabetesCompletedNCT01469065Phase 1Results posted
- Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 DiabetesCompletedNCT01396187Phase 1Results posted
- A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic PatientsCompletedNCT01396161Phase 1Results posted
- Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 DiabetesCompletedNCT01338870Phase 2Results posted
- Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes MellitusCompletedNCT01336738Phase 2Results posted
- Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesCompletedNCT01301456Phase 1Results posted
- A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes PatientsCompletedNCT01298518Phase 1Results posted
- Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 DiabetesCompletedNCT01285518Phase 1Results posted
- Multiple Dose Study Of PF-04937319 In Patients With Type 2 DiabetesCompletedNCT01272804Phase 1Results posted
- A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes MellitusCompletedNCT01044537Phase 1Results posted
- A Safety and Pharmacokinetic Study of CVX-096 in Type 2 DiabeticsCompletedNCT00886821Phase 1Results posted
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 DiabetesTerminatedNCT00527397Phase 3Results posted
- A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.TerminatedNCT00437489Phase 4Results posted
- This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes MellitusCompletedNCT00418522Phase 4Results posted
- A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®CompletedNCT00391027Phase 4Results posted
- A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes MellitusTerminatedNCT00282971Phase 3Results posted
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active, not recruitingNCT07400653Phase 3
- A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DMCompletedNCT06897202Phase 2
- A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes MellitusCompletedNCT06279234Phase 1
- A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking MetforminTerminatedNCT02053116Phase 2
- A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking MetforminTerminatedNCT02053103Phase 2
- A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet FormulationCompletedNCT01821079Phase 1
- Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedNCT01807377Phase 1
- Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult SubjectsCompletedNCT01794364Phase 1
- Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedNCT01757756Phase 1
- A Study To Evaluate The Effects Of PF-05175157 In Healthy VolunteersCompletedNCT01537497Phase 1
- A Study Of Three PF-05190457 Formulations In Healthy VolunteersCompletedNCT01522807Phase 1
- A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult SubjectsCompletedNCT01469468Phase 1
- A Study To Evaluate PF-05175157 In Healthy VolunteersCompletedNCT01433380Phase 1
- A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic PatientsTerminatedNCT01372163Phase 1
- Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532CompletedNCT01369602Phase 1
- A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532CompletedNCT01369277Phase 1
- A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its AbsorptionCompletedNCT01366287Phase 1
- A Study Of PF-05175157 In Healthy VolunteersCompletedNCT01274663Phase 1
- Single Dose Escalation Study of PF-05190457 in Healthy VolunteersCompletedNCT01247896Phase 1
- A Multiple Dose Study Of PF-05161704 In Healthy VolunteersTerminatedNCT01202266Phase 1
- A Single Dose Study Of PF-05161704 In Healthy VolunteersCompletedNCT01183715Phase 1
- Multiple Dose Study of PF-04991532 in Patients With Type 2 DiabetesCompletedNCT01129258Phase 1
- Single Dose Study of PF-04991532 in Healthy SubjectsCompletedNCT01102673Phase 1
- A Safety Study of ARRY-403 in Patients With Type 2 DiabetesCompletedNCT00952198Phase 1
- A Safety Study of ARRY-403 in Patients With Type 2 DiabetesCompletedNCT00859755Phase 1
- Single-Dose Study Of PF-04603629 In Type 2 Diabetic SubjectsCompletedNCT00638313Phase 1
- Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes MellitusTerminatedNCT00637338Phase 1
- Effect of PF-00734200 in Subjects With Type 2 DiabetesCompletedNCT00618007Phase 2
- Bioequivalence Study Of Glucotrol XL 2.5 Mg TabletsCompletedNCT00550329
- 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With MetforminCompletedNCT00473525Phase 2
- A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-WeeksTerminatedNCT00427401Phase 2
- Study Evaluating PPM-204 In Subjects With Type 2 DiabetesTerminatedNCT00425919Phase 2
- Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 DiabetesCompletedNCT00424411Phase 3
- Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.CompletedNCT00370565Phase 3
- A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and LantusCompletedNCT00367445Phase 4
- Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or RosiglitazoneTerminatedNCT00282945Not applicable
- US Inhaled Insulin Dose Titration StudyCompletedNCT00246623Phase 3
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143338Phase 2
- US Inhaled Insulin Therapeutic Choice Questionnaire StudyCompletedNCT00139763Phase 3